Camden National Bank Novartis Ag Transaction History

Camden National Bank

  • $651 Million
  • Q1 2025

A detailed history of Camden National Bank transactions in Novartis Ag stock. As of the latest transaction made, Camden National Bank holds 72,308 shares of NVS stock, worth $8.37 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
72,308
Previous 73,509 1.63%
Holding current value
$8.37 Million
Previous $7.15 Million 12.68%
% of portfolio
1.24%
Previous 1.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$97.14 - $115.57 $116,665 - $138,799
-1,201 Reduced 1.63%
72,308 $8.06 Million
Q4 2024

Feb 07, 2025
SELL
$96.78 - $117.18 $41,518 - $50,270
-429 Reduced 0.58%
73,509 $7.15 Million
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $153,251 - $174,565
-1,444 Reduced 1.92%
73,938 $8.5 Million
Q2 2024

Aug 13, 2024
BUY
$92.57 - $107.37 $952,545 - $1.1 Million
10,290 Added 15.81%
75,382 $8.03 Million
Q1 2024

Apr 30, 2024
SELL
$95.27 - $108.47 $133,663 - $152,183
-1,403 Reduced 2.11%
65,092 $6.3 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $49,918 - $54,933
-541 Reduced 0.81%
66,495 $6.71 Million
Q3 2023

Nov 03, 2023
SELL
$94.73 - $105.13 $46,512 - $51,618
-491 Reduced 0.73%
67,036 $6.83 Million
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $108,618 - $123,164
-1,174 Reduced 1.71%
67,527 $6.81 Million
Q1 2023

May 08, 2023
BUY
$80.03 - $92.81 $41,535 - $48,168
519 Added 0.76%
68,701 $6.32 Million
Q4 2022

Feb 10, 2023
SELL
$75.55 - $92.52 $19,718 - $24,147
-261 Reduced 0.38%
68,182 $6.19 Million
Q3 2022

Nov 04, 2022
BUY
$74.61 - $87.26 $22,979 - $26,876
308 Added 0.45%
68,443 $5.2 Million
Q2 2022

Aug 09, 2022
BUY
$80.52 - $93.75 $138,816 - $161,625
1,724 Added 2.6%
68,135 $5.76 Million
Q1 2022

May 05, 2022
BUY
$80.11 - $90.62 $22,831 - $25,826
285 Added 0.43%
66,411 $5.83 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $38,893 - $43,007
-488 Reduced 0.73%
66,126 $5.78 Million
Q3 2021

Nov 09, 2021
BUY
$81.78 - $95.14 $117,681 - $136,906
1,439 Added 2.21%
66,614 $5.45 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $52,337 - $57,808
-614 Reduced 0.93%
65,175 $5.95 Million
Q1 2021

Aug 04, 2021
SELL
$83.5 - $98.47 $51,686 - $60,952
-619 Reduced 0.93%
65,789 $5.62 Million
Q4 2020

Feb 01, 2021
SELL
$78.07 - $94.43 $197,360 - $238,719
-2,528 Reduced 3.67%
66,408 $6.27 Million
Q3 2020

Nov 05, 2020
BUY
$82.14 - $91.0 $44,027 - $48,776
536 Added 0.78%
68,936 $6 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $13,515 - $15,213
167 Added 0.24%
68,400 $5.97 Million
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $622,320 - $871,882
-8,806 Reduced 11.43%
68,233 $5.63 Million
Q4 2019

Feb 11, 2020
BUY
$84.35 - $95.37 $220,912 - $249,774
2,619 Added 3.52%
77,039 $7.3 Million
Q3 2019

Oct 11, 2019
BUY
$85.54 - $94.26 $69,201 - $76,256
809 Added 1.1%
74,420 $6.47 Million
Q2 2019

Aug 08, 2019
BUY
$75.4 - $92.8 $43,204 - $53,174
573 Added 0.78%
73,611 $6.72 Million
Q1 2019

May 08, 2019
BUY
$75.32 - $86.15 $58,523 - $66,938
777 Added 1.08%
73,038 $7.02 Million
Q4 2018

Feb 04, 2019
BUY
$73.66 - $82.02 $280,497 - $312,332
3,808 Added 5.56%
72,261 $6.2 Million
Q3 2018

Nov 08, 2018
BUY
$66.94 - $77.43 $170,563 - $197,291
2,548 Added 3.87%
68,453 $5.9 Million
Q2 2018

Aug 10, 2018
BUY
$64.91 - $73.36 $427,497 - $483,148
6,586 Added 11.1%
65,905 $4.98 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $67,715 - $80,952
962 Added 1.65%
59,319 $4.8 Million
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $68,424 - $73,447
946 Added 1.65%
58,357 $4.9 Million
Q3 2017

Nov 09, 2017
BUY
$74.14 - $77.27 $4.26 Million - $4.44 Million
57,411
57,411 $4.93 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Camden National Bank Portfolio

Follow Camden National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email